详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Ye, Ding-Wei[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] * ; Gu, Weijie[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Han, Weiqing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Luo, Hong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Zhou, Fangjian[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; He, Dalin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Ma, Lulin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Guo, Hongqian[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Liang, Chaozhao[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Chong, Tie[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Jiang, Jun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Chen, Zhiwen[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Wang, Yong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Zou, Qing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Tian, Ye[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Xiao, Jun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Huang, Jian[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Yang, Xinfeng[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Li, Junliang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Jin, Chunlei[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ;

单位： [1]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China [2]Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Hunan Canc Ctr, Changsha, Peoples R China [3]Chongqing Univ, Canc Hosp, Chongqing Canc Hosp, Chongqing, Peoples R China [4]Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China [5]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [6]Peking Univ Third Hosp, Beijing, Peoples R China [7]Nanjing Drum Tower Hosp, Nanjing, Peoples R China [8]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China [9]Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China [10]Army Med Univ, Daping Hosp, Chongqing, Peoples R China [11]Army Med Univ, Southwest Hosp, Chongqing, Peoples R China [12]Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China [13]Jiangsu Canc Hosp, Nanjing, Peoples R China [14]Capital Med Univ, Beijing Friendly Hosp, Beijing, Peoples R China [15]USTC, Affiliated Hosp 1, Anhui Prov Hosp, Hefei, Peoples R China [16]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China [17]Jiangsu Hengrui Pharmaceut Co Ltd, Clin Res & Dev, Shanghai, Peoples R China [18]Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China

出处：

ISSN：

基金：

语种：

WOS：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2020]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者单位： [1]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China [2]Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Hunan Canc Ctr, Changsha, Peoples R China [3]Chongqing Univ, Canc Hosp, Chongqing Canc Hosp, Chongqing, Peoples R China [4]Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China [5]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [6]Peking Univ Third Hosp, Beijing, Peoples R China [7]Nanjing Drum Tower Hosp, Nanjing, Peoples R China [8]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China [9]Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China [10]Army Med Univ, Daping Hosp, Chongqing, Peoples R China [11]Army Med Univ, Southwest Hosp, Chongqing, Peoples R China [12]Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China [13]Jiangsu Canc Hosp, Nanjing, Peoples R China [14]Capital Med Univ, Beijing Friendly Hosp, Beijing, Peoples R China [15]USTC, Affiliated Hosp 1, Anhui Prov Hosp, Hefei, Peoples R China [16]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China [17]Jiangsu Hengrui Pharmaceut Co Ltd, Clin Res & Dev, Shanghai, Peoples R China [18]Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

A phase 3 trial of SHR3680 versus bicalutamide in combination with androgen deprivation therapy (ADT) in patients with high-volume metastatic hormone-sensitive prostate cancer (mHSPC)

文献详情